CUSIP: 492515101
What is CUSIP 492515101?
CUSIP 492515101 identifies KERX - KERYX BIOPHARMACEUTICALS - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 492515101:
As of 31 Dec 2025, 1 institutional investors reported holding 1 shares of KERYX BIOPHARMACEUTICALS - COMMON STOCK (KERX).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 1 | $3 | $3.00 | 1 | |
| 2025 Q3 | 1 | $3 | $3.00 | 1 | |
| 2025 Q2 | 1 | $3 | $3.00 | 1 | |
| 2025 Q1 | 1 | $3 | $3.00 | 1 | |
| 2024 Q4 | 1 | $3 | $3.00 | 1 | |
| 2024 Q3 | 1 | $3 | $3.00 | 1 | |
| 2024 Q2 | 1 | $3 | $3.00 | 1 | |
| 2024 Q1 | 1 | $3 | $3.00 | 1 | |
| 2023 Q4 | 1 | $3 | $3.00 | 1 | |
| 2023 Q3 | 1 | $3 | $3.00 | 1 | |
| 2023 Q2 | 1 | $3 | $3.00 | 1 | |
| 2023 Q1 | 1 | $3 | $3.00 | 1 | |
| 2022 Q4 | 1 | $3 | +$3 | $3.00 | 1 |
| 2018 Q4 | 0 | $0 | -$252,722,815 | $3.00 | 0 |
| 2018 Q3 | 74,365,398 | $252,825,495 | -$3,991,681 | $3.40 | 117 |
| 2018 Q2 | 75,279,174 | $283,248,825 | -$5,512,639 | $3.76 | 130 |
| 2018 Q1 | 76,537,811 | $313,031,147 | -$5,474,810 | $4.09 | 122 |
| 2017 Q4 | 77,997,170 | $362,688,397 | -$32,337,869 | $4.65 | 126 |
| 2017 Q3 | 79,316,434 | $563,154,880 | -$628,742 | $7.10 | 131 |
| 2017 Q2 | 79,418,794 | $574,182,277 | +$77,465,831 | $7.23 | 126 |
| 2017 Q1 | 68,789,466 | $423,701,864 | +$38,729,544 | $6.16 | 118 |
| 2016 Q4 | 68,022,562 | $398,611,098 | +$6,619,972 | $5.86 | 120 |
| 2016 Q3 | 66,992,159 | $355,267,511 | +$1,799,369 | $5.31 | 113 |
| 2016 Q2 | 66,373,956 | $439,416,816 | -$4,341,017 | $6.62 | 116 |
| 2016 Q1 | 67,066,576 | $313,155,834 | -$27,595,337 | $4.67 | 125 |
| 2015 Q4 | 73,183,540 | $369,538,979 | -$72,467,293 | $5.05 | 124 |
| 2015 Q3 | 90,710,688 | $313,029,185 | -$52,836,088 | $3.52 | 134 |
| 2015 Q2 | 92,009,907 | $918,210,256 | -$41,707,073 | $9.98 | 148 |
| 2015 Q1 | 93,527,014 | $1,190,054,374 | +$214,191,008 | $12.73 | 154 |
| 2014 Q4 | 76,510,160 | $1,082,351,612 | +$7,946,471 | $14.15 | 144 |
| 2014 Q3 | 75,830,993 | $1,042,439,039 | +$89,791,074 | $13.75 | 138 |
| 2014 Q2 | 67,404,672 | $1,036,672,414 | -$29,160,570 | $15.38 | 134 |
| 2014 Q1 | 67,212,223 | $1,144,703,110 | +$286,822,120 | $17.04 | 149 |